Feasibility of a Blended Therapy Approach (bletheRD)

Feasibility of a Blended Therapy Approach: Face-to-face Physiotherapy Sessions Combined With an Interactive Tablet-based Exercise Program for People With Rare Diseases.

Exercise is an important part of therapy guidelines in the rehabilitation of rare diseases (RDs) as Haemophilia and Myositis. The aim of this study is not to evaluate a new therapy intervention, but to evaluate the delivery of this intervention. In clinical practice, patients are usually instructed to perform an exercise program at home. Normally, a physiotherapist (PT) provides an instruction (paper-) sheet. In this study, the investigators evaluate the feasibility of an interactive tablet-based way of delivery. The exercise program is - as usual in physiotherapy - individually tailored by the PT.

Study Overview

• Status: Completed
• Conditions: Feasibility; Exercise; Telemedicine; Myositis; Haemophilia
• Intervention / Treatment: Other: Dividat FIT

Detailed Description

Myositis and haemophilia belong with a prevalence rate of 0.4-17.3 of 100'000 and 2-12 of 100'000, respectively to the group of RDs. The fact that a RD affects only a small number of people, indicates that rehabilitation knowledge outside the specialised medical centers is rare. Thus, since many people with RD do not live nearby these institutions, they do not have direct acces to rehabilitation programmes. The University Hospital Zurich (USZ) offers medical treatment and Rehabilitation Support in such reference centers, among others for people with myositis (PWM) and for people with haemophilia (PWH).

Although these two diseases differ strongly in their underlying cause, affected persons are confronted with similar problems: PWM and PWH suffer from musculoskeletal problems and therefore, a physically active lifestyle is essential to maintain good health. Nevertheless, PWM and PWH were previously discouraged from participating in physical exercise. Consequently, both groups are less physically active, have a lower fitness level and a higher risk for comorbidities, compared to healthy people. Nowadays, the beneficial effects of exercise in PWH and in PWM are well accepted and there is evidence that PWH and PWM profit from physical exercise programs.

Despite the encouraging benefits of physical exercise in PWH and PWM, these may be challenged with more barriers to start and maintain an exercise program, compared to healthy persons, e.g. due to reduced accessibility of specialised physiotherapists.

Telerehabilitation (TR), a subfield of telemedicine, may help to overcome some of the barriers to exercise regularly and connect PWH/PWM with specialised physiotherapists. TR is defined as the provision of rehabilitation services from a distance using telecommunication technologies as the delivery medium. This approach may optimize the timing, intensity and sequencing of interventions and provide opportunities for individuals to receive rehabilitation in their own social and professional environments from disease-specialised caregivers. An additional advantage of TR is the possibility to implement different persuasive technologies such as personalisation, self-monitoring, tailoring, goal setting, comparison and conditioning through positive and negative reinforcement in the development of exercise programmes. These technologies help to make exercise programmes more enjoyable and, therefore, enhance patients' motivation to exercise regularly.

Furthermore, the importance of individual and social support has been emphasized in several reviews evaluating health behaviour change for example becoming more active. This kind of support can be integrated in the design of a TR program and it can further be enhanced by blending TR with face-to-face sessions. The so-called blended therapy is a promising approach combining the advantages from traditional rehabilitation and new technologies.

The aim of this study is to evaluate feasibility of a blended therapy approach, combining a tablet-based exercise program, called "Dividat Fit" with face-to-face therapy sessions for PWH and PWM.

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Switzerland
  • Zürich, Switzerland, 8091
    • Ruud Knols

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

Diagnosis of mild Haemophilia or Myositis

• able to walk 20 meters without walking aids
• currently exercising less than one training session per week (training = vigorous activity)
• maintenance of a stable medical regimen for 4 weeks prior to initiation of study and considered to maintain a stable regimen for the course of the study
• signed informed consent to participate in the study

Exclusion Criteria:

• Clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, severe cardiovascular and/or pulmonary disease, severe osteoporosis, pulmonary hypertension, pain syndrome, paresis)
• Contraindications to physical exercise for People with Haemophila: Factor-prophylaxis-regimen, inhibitor positive, less than 6 months after arthroplasty surgery, acute joint or muscle bleeding within the last 30 days for People With Myosites: acute exacerbation of inflammation
• Known or suspected non-compliance, drug or alcohol abuse,
• Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
• Participation in another study with investigational drug within the 30 days preceding and during the present study
• Known pregnancy or breastfeeding

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Dividat FIT: Computer based exercise; One arm with 10-15 Haemophilia patients and 10-15 Myositis patients.	Other: Dividat FIT; The study intervention is a blended therapy approach of face-to-face physiotherapy sessions with an interactive tablet-based home exercise program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of patients recruited in the study	Recruitment rate, reasons for denial and exlusion and drop-outs	Will be assessed approximately 6 months after start of study

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Adherence to the "Dividat Fit" exercise program	Number of completed training sessions	Will be assessed approximately 6 months after start of study
Perceived usefulness and perceived ease of use of Dividat Fit	Technology Assessment Model Questionnaire : 7-point Likert scale ranging from "strongly disagree" (rated as 1) to "strongly agree" (rated as 7). The TAM model can explain the users' motivation by three factors in subscales: perceived ease of use, perceived usefulness and attitude toward using the Technology.	10 Minutes for each patient after the end of the 12-week intervention program
Perceived satisfaction of Dividat FIT	Satisfaction Questionnaire : 5-point Likert scale ranging from "strongly agree" (rated as 1) to "strongly disagree" (rated as 5). The model can explain the users' satisfaction rating by following factors in subscales: Satisfaction of physiotherapy sessions, satisfaction of the home program, satisfaction of the technical aspects and aspects that improved the motivation for the computer exercise program.	10 Minutes for each patient after the end of the 12-week intervention program
Hand-held dynamometry	Isometric Muscle Force	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.
Manual Muscle testing	MMT8 only for People with Myosites	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.
Expanded Timed Get-up-and-Go	ETGUG	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.
30 second chair stand	Chair raise	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.
30 second arm curl	lift a 1 kg weight above the head until the elbow is fully extended in a 30 second period at a comfortable pace	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.
Functional Index 2 Test (FI2) : Number of repetitions for muscle endurance	In the FI2 test, patients perform as many repetitions for the subscales schoulder flexion, shoulder abduction, head lift, hip flexion, step test, heel lift and toe lift at a standardised movement pace untill a maximal number of correct repetitions is reached (60 repetitions for shoulder flexion, shoulder abduction, head lift, hip flexion and step test and 120 repetitions for heel lift and toe lift).If the patient cannot keep up the pace or perform the correct movement, then the amount of the correctly performed repetitions for a subscale is noted.	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.
Stanford Health Assessment Questionnaire Disability Index (HAQ)	The HAQ consists of 20 questions divided into eight subscales on a 4 Point likert scale: Dressing, rising, eating, walking, hygiene, reaching, grip function, and performing activities. Each question asks on a scale ranging from 0 to 3 if the categories can be performed without any difficulty (scale 0) up to cannot be done at all (scale 3). The summed subscores are divided by 8, to receive the total score.	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.
Health related disability and quality of life (SF-36)	The SF-36 is a generic patient-reported outcome measure aimed at quantifying health related quality of life (HRQOL). The SF-36 includes 36 questions divided in eight subscales: Limitations in physical activities because of health problems, limitations in social activities because of physical or emotional problems; limitations in usual role activities because of physical health problems; bodily pain; general mental health (psychological distress and well-being), limitations in usual role activities because of emotional problems, vitality (energy and fatigue), general health perceptions. The eight subscales can be divided into two main components: physical component summary (PCS) and mental component summary (MCS). In the two main components higher scores indicate better HRQOL.	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.
Myositis Activity Profile questionnaire (MAP)	The MAP includes 32 items which can be answered on a 7-point Likert scale; where 1= no difficulty to perform and 7= impossible to perform. These items are divided into four subscales (movement activities, activities of moving around, personal care, and domestic activities) and four single items (keeping in touch with close friends and relatives, avoiding overexertion during daily activities, being able to cope with work and/or housework to a satisfactory degree, and being able to do recreational activities of choice).	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.
Haemophilia & Exercise Project-Test-Questionnaire (HEP-Test-Q)	The HEP-Test-Q is a questionnaire, assessing subjective physical performance of patients with haemophilia. It consists of 25 items pertaining to four domains "mobility", "strength & coordination", "endurance" and "body perception" and one single item, which assesses changes in physical functioning in comparison to the previous year. Each item can be answered on a 5-point ordinal scale varying from 1 (never) to five (always).	Measurement approximately, two weeks before the start of the exercise intervention and after the end of the 12-week intervention program.

Collaborators and Investigators

• Sponsor: University of Zurich
• Investigators: Principal Investigator: Ruud Knols, PhD, University of Zurich

Publications and helpful links

General Publications

• Pfister PB, Knols RH, de Bie RA, de Bruin ED. Feasibility of a blended therapy approach in the treatment of patients with inflammatory myopathies. Arch Physiother. 2021 May 27;11(1):14. doi: 10.1186/s40945-021-00108-z.

Study record dates

Study Major Dates

• Study Start (Actual): February 27, 2019
• Primary Completion (Actual): April 30, 2020
• Study Completion (Actual): April 30, 2020

Study Registration Dates

• First Submitted: August 29, 2018
• First Submitted That Met QC Criteria: October 18, 2018
• First Posted (Actual): October 19, 2018

Study Record Updates

• Last Update Posted (Actual): July 2, 2020
• Last Update Submitted That Met QC Criteria: July 1, 2020
• Last Verified: July 1, 2020

More Information

Terms related to this study

• Keywords: Telemedicine, Feasibility, Exercise
• Additional Relevant MeSH Terms: Nervous System Diseases; Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases; Myositis
• Other Study ID Numbers: 2018-00970

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No